Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries.
about
Threshold and subthreshold generalized anxiety disorder among US adolescents: prevalence, sociodemographic, and clinical characteristicsCulture and the anxiety disorders: recommendations for DSM-V.A longitudinal etiologic model for symptoms of anxiety and depression in women.Generalized anxiety disorder and anorexia nervosa: evidence of shared genetic variationCommon psychiatric disorders and caffeine use, tolerance, and withdrawal: an examination of shared genetic and environmental effects.Broadening of Generalized Anxiety Disorders Definition Does not Affect the Response to Psychiatric Care: Findings from the Observational ADAN Study.Current concept of anxiety: implications from Darwin to the DSM-V for the diagnosis of generalized anxiety disorder.Cross-cultural variations in the prevalence and presentation of anxiety disorders.The Classification of Anxiety and Fear-Related Disorders in the ICD-11.Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe.Epidemiology of anxiety disorders: from surveys to nosology and back.Generalized anxiety disorder with and without excessive worry in Hong Kong.Dimensions of psychotic experiences among women in the general population.Psychometric properties of the Generalized Anxiety Disorder Questionnaire - IV (GAD-Q-IV) in postpartum mothers.Letter: dyspepsia, anxiety and depression - authors' reply.The effect of the draft DSM-5 criteria for GAD on prevalence and severity.
P2860
Q33838692-194E9149-5958-425D-9F27-C3D911B90D49Q35110512-294EF35A-7782-4B84-A8F8-1F13AF074AD7Q35184583-0092C79E-145C-46CD-8EE3-15EAF27842B2Q35815217-157E010D-7811-41DE-9251-971E72AB471AQ36237747-A6E35628-5FC4-41F7-B0AD-E4989E6F34FDQ36414967-181544BC-F8FB-4D5A-B818-802680D8F1EAQ37778331-B2F3FFD9-7BEC-438C-914E-8F8C525366C0Q37838435-C02EBF58-E7FA-4BCA-BD67-03BC363F1A96Q38895299-AB41B0EC-BF77-4B0C-BA6D-20373FC4D308Q38905913-73020503-0B83-422B-A9CD-5FA44326AE90Q39312246-3690CAAD-7001-43FF-9437-C19EF9BBF710Q39973710-D01B3035-2649-47AA-BFF0-593841A3FE9DQ45375500-722A5A7B-3BE5-473F-8BBE-205D96384C69Q45978368-217E1A91-2907-4128-966E-80C4AFC9879BQ48567992-D9F95716-5C2D-41C5-A924-BB122518B1A2Q49055690-3912D258-004B-4EF4-ACA8-B3F5A629A7F8
P2860
Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Implications of modifying the ...... oped and developing countries.
@en
Implications of modifying the ...... oped and developing countries.
@nl
type
label
Implications of modifying the ...... oped and developing countries.
@en
Implications of modifying the ...... oped and developing countries.
@nl
prefLabel
Implications of modifying the ...... oped and developing countries.
@en
Implications of modifying the ...... oped and developing countries.
@nl
P2093
P2860
P1476
Implications of modifying the ...... oped and developing countries.
@en
P2093
A M Ruscio
D Levinson
E J Bromet
G de Girolamo
J Posada-Villa
J-P Lepine
K Demyttenaere
P2860
P304
P356
10.1017/S0033291708004807
P407
P577
2008-12-18T00:00:00Z